Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning
暂无分享,去创建一个
[1] P. Ferdinandy,et al. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning , 2015, British journal of pharmacology.
[2] J. DiNicolantonio,et al. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: A meta‐analysis of randomized controlled trials , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] F. Gao,et al. Effect of Remote Ischemic Preconditioning in the Elderly Patients With Coronary Artery Disease With Diabetes Mellitus Undergoing Elective Drug-Eluting Stent Implantation , 2014, Angiology.
[4] T. Rassaf,et al. S-nitrosation of mitochondrial connexin 43 regulates mitochondrial function , 2014, Basic Research in Cardiology.
[5] Peter Libby,et al. Cardiovascular remodelling in coronary artery disease and heart failure , 2014, The Lancet.
[6] G. Baxter,et al. Novel Approaches and Opportunities for Cardioprotective Signaling Through 3′,5′-Cyclic Guanosine Monophosphate Manipulation , 2014, Journal of cardiovascular pharmacology and therapeutics.
[7] U. Frey,et al. Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation , 2014, Acta anaesthesiologica Scandinavica.
[8] H. Bøtker,et al. Remote ischemic preconditioning impairs ventricular function and increases infarct size after prolonged ischemia in the isolated neonatal rabbit heart. , 2014, The Journal of thoracic and cardiovascular surgery.
[9] Z. Giricz,et al. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. , 2014, Journal of molecular and cellular cardiology.
[10] P. Ferdinandy,et al. Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective. , 2014, Pharmacological research.
[11] P. Ferdinandy,et al. Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide. , 2014, American journal of physiology. Heart and circulatory physiology.
[12] H. Bøtker,et al. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. , 2014, European heart journal.
[13] Y. Jeon,et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. , 2014, European heart journal.
[14] P. Ferdinandy,et al. Nitrite in organ protection , 2014, British journal of pharmacology.
[15] G. Heusch,et al. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. , 2014, The Journal of thoracic and cardiovascular surgery.
[16] C. Chu,et al. Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion. , 2014, Cardiovascular research.
[17] Pengyu Jia,et al. Hypercholesterolemia Abrogates the Cardioprotection of Ischemic Postconditioning in Isolated Rat Heart: Roles of Glycogen Synthase Kinase-3β and the Mitochondrial Permeability Transition Pore , 2014, Cell Biochemistry and Biophysics.
[18] M. Gilard,et al. The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction , 2014, Basic Research in Cardiology.
[19] Suraj Khanal,et al. Effect of early metoprolol on infarct size in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial , 2013, Indian Heart Journal.
[20] C. Brizard,et al. Remote ischemic preconditioning in cyanosed neonates undergoing cardiopulmonary bypass: a randomized controlled trial. , 2013, The Journal of thoracic and cardiovascular surgery.
[21] G. Heusch,et al. The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation. , 2013, Current pharmaceutical design.
[22] Robert S. Balaban,et al. The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter (MCU) , 2013, Nature Cell Biology.
[23] G. Heusch,et al. Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning. , 2013, European heart journal.
[24] Mostafa Ashraf,et al. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[25] E. Abel,et al. Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms. , 2013, Journal of molecular and cellular cardiology.
[26] M. Mocanu,et al. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner , 2013, Cardiovascular Diabetology.
[27] Sang-Wook Kim,et al. Ischemic Postconditioning During Primary Percutaneous Coronary Intervention: The Effects of Postconditioning on Myocardial Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction (POST) Randomized Trial , 2013, Circulation.
[28] S. Möhlenkamp,et al. Aspirate from human stented native coronary arteries vs. saphenous vein grafts: more endothelin but less particulate debris. , 2013, American journal of physiology. Heart and circulatory physiology.
[29] Lei-lei Ma,et al. Hypercholesterolemic Myocardium Is Vulnerable to Ischemia-Reperfusion Injury and Refractory to Sevoflurane-Induced Protection , 2013, PloS one.
[30] Craig Wilson,et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. , 2013, The New England journal of medicine.
[31] Deepak L. Bhatt,et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.
[32] M. Friedrich,et al. No cardioprotective benefit of ischemic postconditioning in patients with ST-segment elevation myocardial infarction. , 2013, Journal of interventional cardiology.
[33] E. Bramucci,et al. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. , 2013, JACC. Cardiovascular interventions.
[34] S. Engel,et al. Sulphonylureas and risk of cardiovascular disease: systematic review and meta‐analysis , 2013, Diabetic medicine : a journal of the British Diabetic Association.
[35] A. Íñiguez,et al. Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial , 2013, Circulation.
[36] J. Campos,et al. Acute Inhibition of Excessive Mitochondrial Fission After Myocardial Infarction Prevents Long‐term Cardiac Dysfunction , 2013, Journal of the American Heart Association.
[37] P. Thompson,et al. Remote ischaemic preconditioning down-regulates kinin receptor expression in neutrophils of patients undergoing heart surgery. , 2013, Interactive cardiovascular and thoracic surgery.
[38] G. Heusch,et al. Myocardial infarction and coronary microvascular obstruction: an intimate, but complicated relationship , 2013, Basic Research in Cardiology.
[39] P. Croisille,et al. Postconditioning attenuates no-reflow in STEMI patients , 2013, Basic Research in Cardiology.
[40] M. Mocanu,et al. Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. , 2013, Cardiovascular research.
[41] P. Ferdinandy,et al. Myocardial Postconditioning Is Lost in Vascular Nitrate Tolerance , 2013, Journal of cardiovascular pharmacology.
[42] D. Shi,et al. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation. , 2013, The Canadian journal of cardiology.
[43] P. Ferdinandy,et al. MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. , 2013, Journal of molecular and cellular cardiology.
[44] Woo-Shik Kim,et al. Cardioprotective Effects of Exenatide in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of Exenatide Myocardial Protection in Revascularization Study , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[45] L. Argaud,et al. Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart , 2013, Basic Research in Cardiology.
[46] M. Neuhäuser,et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial , 2013, The Lancet.
[47] J. Vicencio,et al. Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis , 2013, Basic Research in Cardiology.
[48] D. Hausenloy,et al. Mitochondrial dynamics in cardiovascular health and disease. , 2013, Antioxidants and Redox Signaling.
[49] D. Hausenloy. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science). , 2013, Current pharmaceutical design.
[50] D. Khanna,et al. Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders. , 2013, European journal of pharmacology.
[51] M. Marre,et al. Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[52] G. Borm,et al. Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia-reperfusion injury in humans. , 2013, American journal of physiology. Heart and circulatory physiology.
[53] G. Heusch,et al. Connexin 43 impacts on mitochondrial potassium uptake , 2013, Front. Pharmacol..
[54] Adam J. Brown,et al. Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective Percutaneous Coronary Intervention: The CRISP Stent Trial Long-term Follow-up , 2013, Circulation. Cardiovascular interventions.
[55] T. Dresselaers,et al. Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning. , 2013, The Journal of thoracic and cardiovascular surgery.
[56] Matthew S. Yong,et al. Effect of Remote Ischemic Preconditioning on Phosphorylated Protein Signaling in Children Undergoing Tetralogy of Fallot Repair: A Randomized Controlled Trial , 2013, Journal of the American Heart Association.
[57] J. Scholz,et al. Postoperative Neurocognitive Dysfunction in Patients Undergoing Cardiac Surgery after Remote Ischemic Preconditioning: A Double-Blind Randomized Controlled Pilot Study , 2013, PloS one.
[58] R. Eliashar,et al. The Bitter Fate of the Sweet Heart: Impairment of Iron Homeostasis in Diabetic Heart Leads to Failure in Myocardial Protection by Preconditioning , 2013, PloS one.
[59] P. Ferdinandy,et al. Cardioprotection by Farnesol: Role of the Mevalonate Pathway , 2013, Cardiovascular Drugs and Therapy.
[60] A. Uchida,et al. Effect of Hypoglycemic Agents on Ischemic Preconditioning in Patients With Type 2 Diabetes and Symptomatic Coronary Artery Disease , 2013, Diabetes Care.
[61] A. Kapucu,et al. Hexokinase cellular trafficking in ischemia–reperfusion and ischemic preconditioning is altered in type I diabetic heart , 2013, Molecular Biology Reports.
[62] A. Chagas,et al. High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats , 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[63] M. Mocanu,et al. Glimepiride Treatment Facilitates Ischemic Preconditioning in the Diabetic Heart , 2013, Journal of cardiovascular pharmacology and therapeutics.
[64] N. Chattipakorn,et al. Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia–reperfusion , 2013, Experimental physiology.
[65] D. Holmes,et al. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: A single center randomized sham controlled trial , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[66] Y. Li,et al. Dickkopf-1 (DKK1) phosphatase and tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA interference in the diabetic heart , 2013, Basic Research in Cardiology.
[67] G. Dorn,et al. PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria , 2013, Science.
[68] A. Rodríguez-Sinovas,et al. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia–reperfusion injury and preconditioning protection , 2013, Basic Research in Cardiology.
[69] L. V. Van Laake,et al. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. , 2013, Cardiovascular research.
[70] M. Galagudza,et al. ASSA13-08-15 Influence of the Anaesthesia Technique on the Cardioprotective Effects of the Remote Ischemic Preconditioning in the Patients Undergoing the Aortic Valve Replacement , 2013, Heart.
[71] Chenghui Zhou,et al. β-blockers and volatile anesthetics may attenuate cardioprotection by remote preconditioning in adult cardiac surgery: a meta-analysis of 15 randomized trials. , 2013, Journal of cardiothoracic and vascular anesthesia.
[72] P. Glass,et al. Interactions of GSK-3β with mitochondrial permeability transition pore modulators during preconditioning: age-associated differences. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.
[73] V. Giorgio,et al. Dimers of mitochondrial ATP synthase form the permeability transition pore , 2013, Proceedings of the National Academy of Sciences.
[74] L. Xiong,et al. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart , 2013, Basic Research in Cardiology.
[75] J. Vinten-johansen,et al. The science and clinical translation of remote postconditioning. , 2013, Journal of cardiovascular medicine.
[76] P. Glass,et al. Chronic Tempol treatment restores pharmacological preconditioning in the senescent rat heart. , 2013, American journal of physiology. Heart and circulatory physiology.
[77] G. Heusch,et al. Nitroglycerin does not Interfere with Protection by Remote Ischemic Preconditioning in Patients with Surgical Coronary Revascularization under Isoflurane Anesthesia , 2013, Cardiovascular Drugs and Therapy.
[78] Peter Vandenabeele,et al. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. , 2013, Immunity.
[79] H. Bøtker,et al. Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. , 2013, Cardiovascular research.
[80] D. Yellon,et al. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection , 2013, Basic Research in Cardiology.
[81] L. Galluzzi,et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition , 2013, Cell cycle.
[82] P. Ferdinandy,et al. Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats , 2013, Cardiovascular Diabetology.
[83] G. Heusch. Cardioprotection: chances and challenges of its translation to the clinic , 2013, The Lancet.
[84] S. Möhlenkamp,et al. Coronary aspirate TNFα reflects saphenous vein bypass graft restenosis risk in diabetic patients , 2013, Cardiovascular Diabetology.
[85] L. Opie,et al. Loss of Cardioprotection With Ischemic Preconditioning in Aging Hearts: Role of Sirtuin 1? , 2013, Journal of cardiovascular pharmacology and therapeutics.
[86] R. Strasser,et al. Cardioprotection by Ischemic Postconditioning Is Abrogated in Hypertrophied Myocardium of Spontaneously Hypertensive Rats , 2013, Journal of cardiovascular pharmacology.
[87] B. Yin,et al. Ischemic postconditioning may increase serum fetuin-A level in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous intervention. , 2013, Clinical laboratory.
[88] K. Wita,et al. Effect of postconditioning on infarction size, adverse left ventricular remodeling, and improvement in left ventricular systolic function in patients with first anterior ST‑segment elevation myocardial infarction. , 2013, Polskie Archiwum Medycyny Wewnetrznej.
[89] J. Zweier,et al. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation. , 2013, Cardiovascular research.
[90] D. Morin,et al. Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities. , 2013, Journal of molecular and cellular cardiology.
[91] M. Mocanu,et al. Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering Phenomenon , 2013, Cardiovascular Drugs and Therapy.
[92] P. Balakumar,et al. Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.
[93] A. Giovagnoni,et al. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. , 2012, International journal of cardiology.
[94] B. R. Shah,et al. Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high‐risk population , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[95] Shengshou Hu,et al. Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trials. , 2012, European heart journal.
[96] P. Ferdinandy,et al. Preconditioning protects the heart in a prolonged uremic condition. , 2012, American journal of physiology. Heart and circulatory physiology.
[97] Yang Cao,et al. Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post‐conditioning in diabetic and non‐diabetic rats , 2012, Clinical and experimental pharmacology & physiology.
[98] Enyi Shi,et al. Diabetes abolishes the cardioprotection induced by sevoflurane postconditioning in the rat heart in vivo: roles of glycogen synthase kinase-3β and its upstream pathways. , 2012, The Journal of surgical research.
[99] J. Bogaert,et al. Impact of gender differences on myocardial salvage and post-ischaemic left ventricular remodelling after primary coronary angioplasty: new insights from cardiovascular magnetic resonance. , 2012, European heart journal cardiovascular Imaging.
[100] L. Opie,et al. Influence of Tumour Necrosis Factor Alpha on the Outcome of Ischaemic Postconditioning in the Presence of Obesity and Diabetes , 2012, Experimental diabetes research.
[101] Å. Gustafsson,et al. Mitochondria and Mitophagy: The Yin and Yang of Cell Death Control , 2012, Circulation research.
[102] W. Oyen,et al. Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study , 2012, Cardiovascular Diabetology.
[103] F. Ying,et al. COMPARISON OF CARDIOPROTECTIVE EFFICACY RESULTING FROM A COMBINATION OF ATORVASTATIN AND ISCHAEMIC POSTCONDITIONING IN DIABETIC AND NON-DIABETIC RAT MODELS , 2012, Heart.
[104] H. Bøtker,et al. Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop , 2012, Basic Research in Cardiology.
[105] N. King,et al. Propofol improves recovery of the isolated working hypertrophic heart from ischaemia–reperfusion , 2012, Pflügers Archiv - European Journal of Physiology.
[106] L. Køber,et al. Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction: A Nationwide Cohort Study , 2012, Circulation.
[107] R. Collins,et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. , 2012, Lancet.
[108] A. Elhan,et al. The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting , 2012, Journal of Cardiothoracic Surgery.
[109] Z. Giricz,et al. Autophagy, Myocardial Protection, and the Metabolic Syndrome , 2012, Journal of cardiovascular pharmacology.
[110] Y. Shim,et al. Isoflurane‐induced post‐conditioning in senescent hearts is attenuated by failure to activate reperfusion injury salvage kinase pathway , 2012, Acta anaesthesiologica Scandinavica.
[111] H. Figulla,et al. Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up , 2012, Basic Research in Cardiology.
[112] B. Hemmings,et al. The Akt1 isoform is an essential mediator of ischaemic preconditioning , 2012, Journal of cellular and molecular medicine.
[113] M. Mercola,et al. Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption , 2012, Journal of cellular and molecular medicine.
[114] F. Prinzen,et al. Pacing Postconditioning: Impact of Pacing Algorithm, Gender, and Diabetes on Its Myocardial Protective Effects , 2012, Journal of Cardiovascular Translational Research.
[115] Steven P Jones,et al. The COX-2/PGI2 Receptor Axis Plays an Obligatory Role in Mediating the Cardioprotection Conferred by the Late Phase of Ischemic Preconditioning , 2012, PloS one.
[116] H. Bøtker,et al. Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients , 2012, Basic Research in Cardiology.
[117] Manjeet Singh,et al. Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72 , 2012, Molecular and Cellular Biochemistry.
[118] V. Lomivorotov,et al. Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting. , 2012, Interactive cardiovascular and thoracic surgery.
[119] F. Carmona,et al. Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: a randomized controlled trial. , 2012, The Journal of thoracic and cardiovascular surgery.
[120] Tatjana Rundek,et al. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. , 2012, Archives of internal medicine.
[121] G. Heusch,et al. Calcium antagonists in myocardial ischemia/reperfusion—update 2012 , 2012, Wiener Medizinische Wochenschrift.
[122] T. Miura,et al. Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning , 2012, Cardiovascular Diabetology.
[123] P. Croisille,et al. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. , 2012, Journal of the American College of Cardiology.
[124] A. Papapetropoulos,et al. Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress. , 2012, Cardiovascular research.
[125] S. Farajnia,et al. The Additive Effects of Ischemic Postconditioning and Cyclosporine-A on Nitric Oxide Activity and Functions of Diabetic Myocardium Injured by Ischemia/Reperfusion , 2012, Journal of cardiovascular pharmacology and therapeutics.
[126] J. Holst,et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. , 2012, European heart journal.
[127] D. Yellon,et al. Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy , 2012, Expert opinion on pharmacotherapy.
[128] Carin M. Van Gelder,et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. , 2012, JAMA.
[129] P. Doevendans,et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo , 2012, Basic Research in Cardiology.
[130] Lina Yu,et al. Hypercholesterolemia Abrogates Sevoflurane-Induced Delayed Preconditioning Against Myocardial Infarct in Rats by Alteration of Nitric Oxide Synthase Signaling , 2012, Shock.
[131] R. Erbel,et al. The coronary circulation in cardioprotection: more than just one confounder. , 2012, Cardiovascular research.
[132] J. Vinten-johansen,et al. Endogenous cardioprotection by ischaemic postconditioning and remote conditioning. , 2012, Cardiovascular research.
[133] Qun Chen,et al. Blockade of Electron Transport at the Onset of Reperfusion Decreases Cardiac Injury in Aged Hearts by Protecting the Inner Mitochondrial Membrane , 2012, Journal of aging research.
[134] A. Gourine,et al. Remote ischaemic pre- and delayed postconditioning – similar degree of cardioprotection but distinct mechanisms , 2012, Experimental physiology.
[135] J. Kieswich,et al. Ischemic Conditioning Protects the Uremic Heart in a Rodent Model of Myocardial Infarction , 2012, Circulation.
[136] John Miller,et al. A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol , 2012, Basic Research in Cardiology.
[137] M. Mocanu,et al. The Diabetic Heart: Too Sweet for Its Own Good? , 2012, Cardiology research and practice.
[138] H. Byon,et al. Effect of remote ischaemic preconditioning on ischaemic-reperfusion injury in pulmonary hypertensive infants receiving ventricular septal defect repair. , 2012, British journal of anaesthesia.
[139] E. Lucchinetti,et al. Remote Ischemic Preconditioning Applied during Isoflurane Inhalation Provides No Benefit to the Myocardium of Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery: Lack of Synergy or Evidence of Antagonism in Cardioprotection? , 2012, Anesthesiology.
[140] W. Schlack,et al. Age-related loss of cardiac preconditioning: Impact of protein kinase A , 2012, Experimental Gerontology.
[141] S. Nadtochiy,et al. Ischemic preconditioning: The role of mitochondria and aging , 2012, Experimental Gerontology.
[142] Josef Coresh,et al. Chronic kidney disease , 2012, The Lancet.
[143] Xiaodong Wang,et al. The Mitochondrial Phosphatase PGAM5 Functions at the Convergence Point of Multiple Necrotic Death Pathways , 2012, Cell.
[144] G. Heusch,et al. STAT5 Activation and Cardioprotection by Remote Ischemic Preconditioning in Humans , 2012, Circulation research.
[145] G. Heusch,et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol – a clinical trial , 2012, Acta anaesthesiologica Scandinavica.
[146] P. Ferdinandy,et al. Matrix Metalloproteinase Inhibitors , 2010, Drugs.
[147] G. Heusch. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction? , 2012, European heart journal.
[148] Cholesterol Treatment Trialists' Collaborato. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012 .
[149] Y. Jeon,et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off-pump coronary artery bypass surgery--randomized controlled trial. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[150] H. Pei,et al. Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling , 2012, Basic Research in Cardiology.
[151] Yajing Wang,et al. Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNFα-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice , 2012, Basic Research in Cardiology.
[152] B. Bein,et al. Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study , 2012, Basic Research in Cardiology.
[153] T. Gori,et al. Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study. , 2012, American journal of physiology. Heart and circulatory physiology.
[154] K. Walsh,et al. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. , 2012, American journal of physiology. Heart and circulatory physiology.
[155] M. Masotti,et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. , 2012, European heart journal.
[156] X. Lu,et al. Age-associated differences in gene expression in response to delayed anesthetic preconditioning , 2011, AGE.
[157] J. Pepper,et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial , 2012, Clinical Research in Cardiology.
[158] R. Gladstone,et al. Remote cardioprotection by direct peripheral nerve stimulation and topical capsaicin is mediated by circulating humoral factors , 2012, Basic Research in Cardiology.
[159] N. Standen,et al. Modulation of the nitric oxide metabolism overcomes the unresponsiveness of the diabetic human myocardium to protection against ischemic injury. , 2011, The Journal of surgical research.
[160] R. Antonelli Incalzi,et al. Effect of local and remote ischemic preconditioning on endothelial function in young people and healthy or hypertensive elderly people. , 2011, Atherosclerosis.
[161] J. Ou,et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing heart valve surgery: randomised controlled trial , 2011, Heart.
[162] G. Heusch,et al. Mitochondrial STAT3 Activation and Cardioprotection by Ischemic Postconditioning in Pigs With Regional Myocardial Ischemia/Reperfusion , 2011, Circulation research.
[163] D. Korzick,et al. Local delivery of a PKCε-activating peptide limits ischemia reperfusion injury in the aged female rat heart. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.
[164] S. Lemoine,et al. Mechanisms involved in the desflurane-induced post-conditioning of isolated human right atria from patients with type 2 diabetes. , 2011, British journal of anaesthesia.
[165] R. D. de Boer,et al. Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure , 2011, Cardiovascular diabetology.
[166] J. Downey,et al. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. , 2011, Circulation.
[167] Y. Birnbaum,et al. The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury , 2011, Basic Research in Cardiology.
[168] D. Yellon,et al. Remote Ischemic Conditioning: A Clinical Trial’s Update , 2011, Journal of cardiovascular pharmacology and therapeutics.
[169] Ji Li,et al. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice. , 2011, American journal of physiology. Heart and circulatory physiology.
[170] L. Guarente,et al. SIRT1-mediated acute cardioprotection. , 2011, American journal of physiology. Heart and circulatory physiology.
[171] M. Hayward,et al. Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial , 2011, Basic Research in Cardiology.
[172] Jun-xian Song,et al. Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P , 2011, Regulatory Peptides.
[173] A. Roehl,et al. The effects of metoprolol on hypoxia‐ and isoflurane‐induced cardiac late‐phase preconditioning , 2011, Acta anaesthesiologica Scandinavica.
[174] S. Yao,et al. Effect of limb ischemic preconditioning on myocardial injury in patients undergoing mitral valve replacement surgery. -A randomized controlled trial-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[175] I. Ambudkar,et al. Faculty Opinions recommendation of A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. , 2011 .
[176] Manjeet Singh,et al. Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart , 2011, BMC cardiovascular disorders.
[177] Y. Choi,et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. , 2011, The Journal of thoracic and cardiovascular surgery.
[178] G. Heusch,et al. Nuclear-encoded mitochondrial proteins and their role in cardioprotection. , 2011, Biochimica et biophysica acta.
[179] P. Ferdinandy,et al. Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats , 2011, Lipids in Health and Disease.
[180] V. Mootha,et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter , 2011, Nature.
[181] Chengqun Huang,et al. Preconditioning Involves Selective Mitophagy Mediated by Parkin and p62/SQSTM1 , 2011, PloS one.
[182] E. Ziv,et al. Diabetes Blockade of Sevoflurane Postconditioning Is Not Restored by Insulin in the Rat Heart: Phosphorylated Signal Transducer and Activator of Transcription 3– and Phosphatidylinositol 3-Kinase–mediated Inhibition , 2011, Anesthesiology.
[183] K. Raedschelders,et al. Differences in myocardial PTEN expression and Akt signalling in type 2 diabetic and nondiabetic patients undergoing coronary bypass surgery , 2011, Clinical endocrinology.
[184] M. Briel,et al. Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients. , 2011, European heart journal.
[185] Pál Pacher,et al. Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. , 2011, Circulation.
[186] A. Redington,et al. Repeated Remote Ischemic Postconditioning Protects Against Adverse Left Ventricular Remodeling and Improves Survival in a Rat Model of Myocardial Infarction , 2011, Circulation research.
[187] A. Shah,et al. Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? , 2011, Basic Research in Cardiology.
[188] K. Przyklenk. Efficacy of Cardioprotective ‘Conditioning’ Strategies in Aging and Diabetic Cohorts , 2011, Drugs & aging.
[189] P. Glass,et al. Age‐associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A , 2011, Acta anaesthesiologica Scandinavica.
[190] P. Ferdinandy,et al. Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. , 2011, American journal of physiology. Heart and circulatory physiology.
[191] D. Greiner,et al. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. , 2011, Antioxidants & redox signaling.
[192] P. Glass,et al. Cardioprotection of the aged rat heart by GSK-3beta inhibitor is attenuated: age-related changes in mitochondrial permeability transition pore modulation. , 2011, American journal of physiology. Heart and circulatory physiology.
[193] K. Sumikawa,et al. Roles of Cyclooxygenase 2 in Sevoflurane- and Olprinone-Induced Early Phase of Preconditioning and Postconditioning Against Myocardial Infarction in Rat Hearts , 2011, Journal of cardiovascular pharmacology and therapeutics.
[194] I. Rahman,et al. Lysine deacetylation in ischaemic preconditioning: the role of SIRT1. , 2011, Cardiovascular research.
[195] S. Möhlenkamp,et al. Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological Attenuation , 2011, Circulation research.
[196] S. Garcia,et al. Long-term Follow-up of Patients Undergoing Postconditioning During ST-Elevation Myocardial Infarction , 2011, Journal of cardiovascular translational research.
[197] G. Heusch,et al. Mitochondria in postconditioning. , 2011, Antioxidants & redox signaling.
[198] D. Yellon,et al. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. , 2011, Antioxidants & redox signaling.
[199] Yangde Zhang,et al. A comparison of cardiac post-conditioning and remote pre-conditioning in paediatric cardiac surgery , 2011, Cardiology in the Young.
[200] Aristide C. Chikando,et al. Mitofusin-2 Maintains Mitochondrial Structure and Contributes to Stress-Induced Permeability Transition in Cardiac Myocytes , 2011, Molecular and Cellular Biology.
[201] Z. Xia,et al. Non-invasive limb ischemic pre-conditioning reduces oxidative stress and attenuates myocardium ischemia-reperfusion injury in diabetic rats , 2011, Free radical research.
[202] 堀田 寛之. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts , 2011 .
[203] R. Baghaei. MYOCARDIAL INJURY IS DECREASED BY LATE REMOTE ISCHAEMIC PRECONDITIONING AND AGGRAVATED BY TRAMADOL IN PATIENTS UNDERGOING CARDIAC SURGERY: A RANDOMISED CONTROLLED TRIAL , 2011 .
[204] S. Momomura,et al. Effect of postconditioning in patients with ST-elevation acute myocardial infarction , 2011, Cardiovascular Intervention and Therapeutics.
[205] A. Mishra,et al. [Protective effect of ischemia postconditioning on reperfusion injury in patients with ST-segment elevation acute myocardial infarction]. , 2011, Zhonghua xin xue guan bing za zhi.
[206] Y. Mei,et al. Effect of ischemic postconditioning in correction of tetralogy of Fallot. , 2011, International heart journal.
[207] Yanrui Li,et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 , 2011, Nature Medicine.
[208] L. Opie,et al. Age, genetic characteristics and number of cycles are critical factors to consider for successful protection of the murine heart with postconditioning. , 2011, Physiological research.
[209] Yang Wu,et al. Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats , 2011, Molecular Biology Reports.
[210] P. Pagliaro,et al. Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats , 2011, Basic Research in Cardiology.
[211] J. Perez-polo,et al. Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin , 2010, Cardiovascular Drugs and Therapy.
[212] Patrick Bruneval,et al. Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[213] W. Schlack,et al. Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[214] Deepak L. Bhatt,et al. Metformin use and mortality among patients with diabetes and atherothrombosis. , 2010, Archives of internal medicine.
[215] W. Luo,et al. Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial. , 2010, The Journal of surgical research.
[216] C. Terkelsen,et al. Remote Ischemic Conditioning in Patients With Myocardial Infarction Treated With Primary Angioplasty: Impact on Left Ventricular Function Assessed by Comprehensive Echocardiography and Gated Single-Photon Emission CT , 2010, Circulation. Cardiovascular imaging.
[217] G. Heusch,et al. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion , 2010, Basic Research in Cardiology.
[218] L. Rydén,et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction , 2010, Heart.
[219] Deepak L. Bhatt,et al. One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry. , 2010, The Canadian journal of cardiology.
[220] J. Farber,et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. , 2010, The Journal of clinical investigation.
[221] H. Bøtker,et al. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations , 2010, Basic Research in Cardiology.
[222] Manjeet Singh,et al. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart. , 2010, European journal of pharmacology.
[223] M. Frenneaux,et al. Response to Letter Regarding Article, “Remote Ischemic Preconditioning in Human Coronary Artery Bypass Surgery: From Promise to Disappointment?” , 2011 .
[224] Y. Jeon,et al. The Effect of Remote Ischaemic Preconditioning on Myocardial Injury in Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery , 2010, Anaesthesia and intensive care.
[225] G. Heusch,et al. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. , 2010, Pharmacology & therapeutics.
[226] P. Ferdinandy,et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. , 2010, Cardiovascular research.
[227] M. Rasouli,et al. Evaluation of the effects of ischemic preconditioning with a short reperfusion phase on patients undergoing a coronary artery bypass graft. , 2010, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[228] Y. Amr,et al. Cardiac Protection During On-Pump Coronary Artery Bypass Grafting: Ischemic Versus Isoflurane Preconditioning , 2010, Seminars in cardiothoracic and vascular anesthesia.
[229] D. Hausenloy,et al. Mitochondrial morphology and cardiovascular disease. , 2010, Cardiovascular research.
[230] Xiangjun Yang,et al. Postconditioning the Human Heart in Percutaneous Coronary Intervention , 2010, Clinical cardiology.
[231] N. Ali,et al. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. , 2010, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[232] P. Glass,et al. Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.
[233] Manjeet Singh,et al. Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart , 2010, Molecular and Cellular Biochemistry.
[234] G. Heusch,et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest , 2010, Basic Research in Cardiology.
[235] Sang-Bing Ong,et al. Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury , 2010, Circulation.
[236] Yu Lin,et al. The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. , 2010, American journal of physiology. Heart and circulatory physiology.
[237] Z. Zuo,et al. Hyperglycemia Inhibits Anesthetic-induced Postconditioning in the Rabbit Heart via Modulation of Phosphatidylinositol-3-kinase/Akt and Endothelial Nitric Oxide Synthase Signaling , 2010, Journal of cardiovascular pharmacology.
[238] Z. Giricz,et al. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation , 2010, Basic Research in Cardiology.
[239] P. Croisille,et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. , 2010, Journal of the American College of Cardiology.
[240] Hong Liu,et al. KATP channel blocker does not abolish the protective effect of Na+/H+ exchange 1 inhibition against ischaemia/reperfusion in aged myocardium , 2010, European journal of anaesthesiology.
[241] C. Terkelsen,et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.
[242] Y. Kwak,et al. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival. , 2010, European journal of pharmacology.
[243] S. Lemoine,et al. Desflurane-induced postconditioning of diabetic human right atrial myocardium in vitro. , 2010, Diabetes & metabolism.
[244] A. Daiber,et al. Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study. , 2010, American journal of physiology. Heart and circulatory physiology.
[245] T. Csont. Nitroglycerin-induced preconditioning: interaction with nitrate tolerance. , 2010, American journal of physiology. Heart and circulatory physiology.
[246] J. Jensen,et al. Cardioprotective Effects of Ischemic Postconditioning in Patients Treated With Primary Percutaneous Coronary Intervention, Evaluated by Magnetic Resonance , 2010, Circulation. Cardiovascular interventions.
[247] R. Henkelman,et al. Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice , 2010, Diabetes.
[248] K. Shimamoto,et al. Short Communication: Angiotensin II Type 1 Receptor–Mediated Upregulation of Calcineurin Activity Underlies Impairment of Cardioprotective Signaling in Diabetic Hearts , 2010, Circulation research.
[249] D. Yellon,et al. Preconditioning the diabetic human myocardium , 2009, Journal of cellular and molecular medicine.
[250] G. Heusch,et al. Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. , 2010, Cardiovascular research.
[251] Charalampos Kossyvakis,et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. , 2010, JACC. Cardiovascular interventions.
[252] D. Yellon,et al. Cardiac preconditioning for ischaemia: lost in translation , 2010, Disease Models & Mechanisms.
[253] P. Pagliaro,et al. Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats , 2010, Basic Research in Cardiology.
[254] S. Mimuro,et al. Landiolol does not enhance the effect of ischemic preconditioning in isolated rat hearts , 2010, Journal of Anesthesia.
[255] I. Andreadou,et al. Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation , 2010, Basic Research in Cardiology.
[256] R. Erbel,et al. Coronary microembolization: from bedside to bench and back to bedside. , 2009, Circulation.
[257] L. Opie,et al. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. , 2009, Cardiovascular research.
[258] Z. Giricz,et al. Hyperlipidaemia induced by a high‐cholesterol diet leads to the deterioration of guanosine‐3′,5′‐cyclic monophosphate/protein kinase G‐dependent cardioprotection in rats , 2009, British journal of pharmacology.
[259] F. Sellke,et al. Effect of Hypercholesterolemia on Myocardial Necrosis and Apoptosis in the Setting of Ischemia-Reperfusion , 2009, Circulation.
[260] K. Shimamoto,et al. Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3β–Mediated Suppression of Mitochondrial Permeability Transition , 2009, Diabetes.
[261] P. Ferdinandy,et al. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. , 2009, American journal of physiology. Heart and circulatory physiology.
[262] R. Nørregaard,et al. CARDIOPROTECTIVE EFFECT OF l‐GLUTAMATE IN OBESE TYPE 2 DIABETIC ZUCKER FATTY RATS , 2009, Clinical and experimental pharmacology & physiology.
[263] Huirong Liu,et al. Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1alpha upregulation. , 2009, Acta biochimica et biophysica Sinica.
[264] I. Netuka,et al. Gender Differences in Cardiac Ischemic Injury and Protection—Experimental Aspects , 2009, Experimental biology and medicine.
[265] Zhiyong Zhang,et al. A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction , 2009, Apoptosis.
[266] Haichang Wang,et al. ISCHAEMIC POST‐CONDITIONING PROTECTS BOTH ADULT AND AGED SPRAGUE‐DAWLEY RAT HEART FROM ISCHAEMIA–REPERFUSION INJURY THROUGH THE PHOSPHATIDYLINOSITOL 3‐KINASE–AKT AND GLYCOGEN SYNTHASE KINASE‐3β PATHWAYS , 2009, Clinical and experimental pharmacology & physiology.
[267] M. Maeng,et al. Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a closed chest porcine ischemia reperfusion model , 2009, BMC cardiovascular disorders.
[268] G. Heusch,et al. Loss of cardioprotection with ageing. , 2009, Cardiovascular research.
[269] K. Sumikawa,et al. Pharmacological Preconditioning in Type 2 Diabetic Rat Hearts: The Roles of Mitochondrial ATP-Sensitive Potassium Channels and the Phosphatidylinositol 3-Kinase-Akt Pathway , 2009, Cardiovascular Drugs and Therapy.
[270] S. Lecour. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? , 2009, Journal of molecular and cellular cardiology.
[271] Yong Huang,et al. Sphingosine protects aging hearts from ischemia/reperfusion injury , 2009, Oxidative medicine and cellular longevity.
[272] E. Iliodromitis,et al. Ischemic postconditioning: experimental models and protocol algorithms , 2009, Basic Research in Cardiology.
[273] E. Golomb,et al. Occult Cardiotoxicity—Toxic Effects on Cardiac Ischemic Tolerance , 2009, Toxicologic pathology.
[274] D. Yellon,et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial , 2009, Heart.
[275] Raphaela P. Kerindongo,et al. Helium-Induced Early Preconditioning and Postconditioning Are Abolished in Obese Zucker Rats in Vivo , 2009, Journal of Pharmacology and Experimental Therapeutics.
[276] R. Kloner,et al. Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats , 2009, Experimental Gerontology.
[277] W. Schlack,et al. Helium-induced late preconditioning in the rat heart in vivo. , 2009, British journal of anaesthesia.
[278] G. Baxter,et al. Pharmacological targets revealed by myocardial postconditioning. , 2009, Current opinion in pharmacology.
[279] D. Yellon,et al. Statins and cardioprotection--more than just lipid lowering? , 2009, Pharmacology & therapeutics.
[280] L. Agulló,et al. Myocardial protection against reperfusion injury: The cGMP pathway , 2009, Thrombosis and Haemostasis.
[281] M. Ovize,et al. Optimal pressure for low pressure controlled reperfusion to efficiently protect ischemic heart: an experimental study in rats. , 2009, Transplantation proceedings.
[282] N. Roewer,et al. Desflurane-induced Postconditioning Is Mediated by β-Adrenergic Signaling: Role of β1- and β2-Adrenergic Receptors, Protein Kinase A, and Calcium/Calmodulin-dependent Protein Kinase II , 2009, Anesthesiology.
[283] D. Yellon,et al. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning , 2009, Basic Research in Cardiology.
[284] L. Sharples,et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial , 2009, Circulation.
[285] P. Doevendans,et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. , 2009, Journal of the American College of Cardiology.
[286] R. Henkelman,et al. GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice , 2009, Diabetes.
[287] W. Luo,et al. Clinical benefit of cardiac ischemic postconditioning in corrections of tetralogy of Fallot. , 2008, Interactive cardiovascular and thoracic surgery.
[288] Zhou Xinmin,et al. Limb Ischemic Preconditioning Reduces Heart and Lung Injury After an Open Heart Operation in Infants , 2009, Pediatric Cardiology.
[289] S. Lemoine,et al. Signaling Pathways Involved in Desflurane-induced Postconditioning in Human Atrial Myocardium In Vitro , 2008, Anesthesiology.
[290] Yu Lin,et al. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice. , 2008, American journal of physiology. Heart and circulatory physiology.
[291] L. Scorrano,et al. Mitofusin 2 tethers endoplasmic reticulum to mitochondria , 2008, Nature.
[292] G. Heusch,et al. Cardioprotection: nitric oxide, protein kinases, and mitochondria. , 2008, Circulation.
[293] H. Drexler,et al. The myocardial JAK/STAT pathway: from protection to failure. , 2008, Pharmacology & therapeutics.
[294] R. Strasser,et al. Cardioprotection by Postconditioning Is Lost in WOKW Rats With Metabolic Syndrome: Role of Glycogen Synthase Kinase 3β , 2008, Journal of cardiovascular pharmacology.
[295] S. Walsh,et al. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[296] W. Schlack,et al. Helium-induced Preconditioning in Young and Old Rat Heart: Impact of Mitochondrial Ca2+-sensitive Potassium Channel Activation , 2008, Anesthesiology.
[297] J. Karliner,et al. Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia. , 2008, Biochemical and biophysical research communications.
[298] Kenichi Watanabe,et al. Attenuation of cardioprotective effect by postconditioning in coronary stenosed rat heart and its restoration by carvedilol. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[299] B. Ghaleh,et al. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. , 2008, American journal of physiology. Heart and circulatory physiology.
[300] Anindita Das,et al. Loss of Myocardial Ischemic Postconditioning in Adenosine A1 and Bradykinin B2 Receptors Gene Knockout Mice , 2008, Circulation.
[301] Nirmal Singh,et al. Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. , 2008, Biological & pharmaceutical bulletin.
[302] K. Garlid,et al. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. , 2008, American journal of physiology. Heart and circulatory physiology.
[303] D. Yellon,et al. Remote ischaemic preconditioning: underlying mechanisms and clinical application. , 2008, Cardiovascular research.
[304] W. Laskey,et al. Concordant improvements in coronary flow reserve and ST‐segment resolution during percutaneous coronary intervention for acute myocardial infarction: A benefit of postconditioning , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[305] Pierre Croisille,et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.
[306] K. Garlid,et al. S3/7 Intramitochondrial signaling — Interactions among mitoKATP, PKCε, ROS, and MPT , 2008 .
[307] J. Karliner,et al. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation. , 2008, Cardiovascular research.
[308] W. Luo,et al. Does cardioplegia leave room for postconditioning in paediatric cardiac surgery?* , 2008, Cardiology in the Young.
[309] K. Heesom,et al. Inhibition of Mitochondrial Permeability Transition Pore Opening by Ischemic Preconditioning Is Probably Mediated by Reduction of Oxidative Stress Rather Than Mitochondrial Protein Phosphorylation , 2008, Circulation research.
[310] C. Darling,et al. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. , 2008, Journal of the American College of Cardiology.
[311] P. Pagel,et al. Simvastatin Restores Ischemic Preconditioning in the Presence of Hyperglycemia through a Nitric Oxide–mediated Mechanism , 2008, Anesthesiology.
[312] Z. Giricz,et al. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts. , 2008, American journal of physiology. Heart and circulatory physiology.
[313] J. Karliner,et al. Sphingosine can pre‐ and post‐condition heart and utilizes a different mechanism from sphingosine 1‐phosphate , 2008, Journal of biochemical and molecular toxicology.
[314] R. Guyton,et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. , 2008, American journal of physiology. Heart and circulatory physiology.
[315] G. Finet,et al. Long-Term Benefit of Postconditioning , 2008, Circulation.
[316] W. Luo,et al. Effect of ischemic postconditioning in adult valve replacement. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[317] R. Mueller,et al. Postconditioning Prevents Reperfusion Injury by Activating &dgr;-Opioid Receptors , 2008, Anesthesiology.
[318] L. Scorrano,et al. Mitofusin 2: a mitochondria-shaping protein with signaling roles beyond fusion. , 2008, Antioxidants & redox signaling.
[319] G. Heusch,et al. Cardioprotection by Ischemic Postconditioning Is Lost in Aged and STAT3-Deficient Mice , 2008, Circulation research.
[320] E. Lucchinetti,et al. Preconditioning by Isoflurane Retains Its Protection Against Ischemia-Reperfusion Injury in Postinfarct Remodeled Rat Hearts , 2008, Anesthesia and analgesia.
[321] B. Gersh. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes , 2008 .
[322] B. Gersh. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials , 2008 .
[323] G. Bhamra,et al. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening , 2008, Basic Research in Cardiology.
[324] P. Pagliaro,et al. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion , 2008, Basic Research in Cardiology.
[325] P. Ferdinandy,et al. Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning , 2007, Pharmacological Reviews.
[326] P. Ferdinandy,et al. Cyclic GMP and protein kinase‐G in myocardial ischaemia‐reperfusion: opportunities and obstacles for survival signaling , 2007, British journal of pharmacology.
[327] A. Hirayama,et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials , 2007, The Lancet.
[328] M. Mocanu,et al. The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore , 2007, Cardiovascular Drugs and Therapy.
[329] R. Gibbons,et al. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. , 2007, American heart journal.
[330] J. Vinten-johansen,et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. , 2007, The Journal of invasive cardiology.
[331] C. Ledent,et al. Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.
[332] Shengshou Hu,et al. Evaluation by Cardiac Troponin I: The Effect of Ischemic Preconditioning as an Adjunct to Intermittent Blood Cardioplegia on Coronary Artery Bypass Grafting , 2007, Journal of cardiac surgery.
[333] Lin Wang,et al. Effects of glibenclamide, glimepiride, and gliclazide on ischemic preconditioning in rat heart. , 2007, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.
[334] M. Hayward,et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial , 2007, The Lancet.
[335] Hiroshi Sato,et al. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. , 2007, American journal of physiology. Heart and circulatory physiology.
[336] D. Yellon,et al. Ischemic preconditioning is lost in aging hypertensive rat heart: Independent effects of aging and longstanding hypertension , 2007, Experimental Gerontology.
[337] R. Gibbons,et al. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). , 2007, The American journal of cardiology.
[338] P. Pagliaro,et al. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. , 2007, Cardiovascular research.
[339] R. Erbel,et al. Review paper The interaction of coronary microembolization and ischemic preconditioning: A third window of cardioprotection through TNF-alpha , 2007 .
[340] B. Vidne,et al. The protective effect of prior ischemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart. , 2007, Interactive cardiovascular and thoracic surgery.
[341] D. Yellon,et al. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection , 2007, Heart Failure Reviews.
[342] G. Heusch,et al. Connexin 43 in ischemic pre- and postconditioning , 2007, Heart Failure Reviews.
[343] W. Luo,et al. Postconditioning in cardiac surgery for tetralogy of Fallot. , 2007, The Journal of thoracic and cardiovascular surgery.
[344] S. Mochizuki,et al. Mitiglinide, a novel oral hypoglycemic agent, preserves the cardioprotective effect of ischemic preconditioning in isolated perfused rat hearts. , 2007, International heart journal.
[345] G. González,et al. Ischemic Postconditioning Reduces Infarct Size by Activation of A1 Receptors and K+ATP Channels in Both Normal and Hypercholesterolemic Rabbits , 2007, Journal of cardiovascular pharmacology.
[346] M. Frenneaux,et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs , 2007, Heart.
[347] J. Downey,et al. The pH Hypothesis of Postconditioning: Staccato Reperfusion Reintroduces Oxygen and Perpetuates Myocardial Acidosis , 2007, Circulation.
[348] M. Hori,et al. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.
[349] I. Konstantinov,et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.
[350] B. Gersh,et al. Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris , 2007, Coronary artery disease.
[351] C. Darling,et al. ’Postconditioning’ the human heart: Multiple balloon inflations during primary angioplasty may confer cardioprotection , 2007, Basic Research in Cardiology.
[352] R. Erbel,et al. Bidirectional Role of Tumor Necrosis Factor-&agr; in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction , 2007, Circulation research.
[353] R. Marquetant,et al. Chronic Angiotensin II Receptor Blockade Induces Cardioprotection During Ischemia by Increased PKC-ϵ Expression in the Mouse Heart , 2007, Journal of cardiovascular pharmacology.
[354] O. V. Evgenov,et al. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential , 2006, Nature Reviews Drug Discovery.
[355] K. Klotz,et al. Role of the β1-Adrenergic Pathway in Anesthetic and Ischemic Preconditioning against Myocardial Infarction in the Rabbit Heart In Vivo , 2006, Anesthesiology.
[356] Kenichi Watanabe,et al. Attenuated cardioprotection by ischemic preconditioning in coronary stenosed heart and its restoration by carvedilol. , 2006, Cardiovascular research.
[357] S. Adamopoulos,et al. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning? , 2006, Heart.
[358] I. Konstantinov,et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. , 2006, Journal of the American College of Cardiology.
[359] Alan Reid,et al. Optimal myocardial protection strategy for coronary artery bypass grafting without cardioplegia: prospective randomised trial. , 2006, Interactive cardiovascular and thoracic surgery.
[360] J. Downey,et al. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. , 2006, Cardiovascular research.
[361] G. Heusch,et al. No loss of cardioprotection by postconditioning in connexin 43-deficient mice , 2006, Basic Research in Cardiology.
[362] Xing-hua Zhang,et al. Effect of postconditioning on coronary blood flow velocity and endothelial function in patients with acute myocardial infarction , 2006, Scandinavian cardiovascular journal : SCJ.
[363] M. Lalu,et al. Hyperlipidemia Attenuates the Infarct Size-Limiting Effect of Ischemic Preconditioning: Role of Matrix Metalloproteinase-2 Inhibition , 2006, Journal of Pharmacology and Experimental Therapeutics.
[364] M. Ovize,et al. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. , 2006, Cardiovascular research.
[365] G. Finet,et al. Postconditioning the Human Heart , 2005, Circulation.
[366] Xiaokui Li,et al. Impairment of Diazoxide-Induced Formation of Reactive Oxygen Species and Loss of Cardioprotection in Connexin 43 Deficient Mice , 2005, Circulation research.
[367] R. Guyton,et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. , 2005, Cardiovascular research.
[368] J. C. Hunter,et al. Age- and sex-dependent alterations in protein kinase C (PKC) and extracellular regulated kinase 1/2 (ERK1/2) in rat myocardium , 2005, Mechanisms of Ageing and Development.
[369] E. Oz,et al. Effects of Ischemic Preconditioning in Human Heart , 2005, Journal of cardiac surgery.
[370] R. Schulz. Pleiotropic effects of statins: acutely good, but chronically bad? , 2005, Journal of the American College of Cardiology.
[371] D. Yellon,et al. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. , 2005, Trends in cardiovascular medicine.
[372] L. Argaud,et al. Postconditioning Inhibits Mitochondrial Permeability Transition , 2005, Circulation.
[373] P. Ferdinandy,et al. Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance. , 2005, Pharmacology & therapeutics.
[374] R. Kloner,et al. Ischemic preconditioning and preinfarction angina in the clinical arena , 2004, Nature Clinical Practice Cardiovascular Medicine.
[375] I. Andreadou,et al. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo. , 2004, European journal of pharmacology.
[376] G. Heusch. Postconditioning: old wine in a new bottle? , 2004, Journal of the American College of Cardiology.
[377] E. Olson,et al. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore , 2004 .
[378] P. Pagel,et al. Cyclooxygenase-2 Mediates Ischemic, Anesthetic, and Pharmacologic Preconditioning In Vivo , 2004, Anesthesiology.
[379] S. Javadov,et al. Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. , 2004, Cardiovascular research.
[380] P. D. del Nido,et al. Cardioprotection afforded by ischemic preconditioning interferes with chronic beta‐blocker treatment , 2004, Scandinavian cardiovascular journal : SCJ.
[381] E. Olson,et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. , 2004, The Journal of clinical investigation.
[382] Z. Szanto,et al. Bradykinin and angiotensin-converting enzyme inhibition in cardioprotection. , 2004, Experimental and clinical cardiology.
[383] L. Becker. Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.
[384] R. Guyton,et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.
[385] S. Ghosh,et al. Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass. , 2003, The Journal of thoracic and cardiovascular surgery.
[386] D. Liem,et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. , 2003, Circulation.
[387] G. Heusch,et al. Late preconditioning against myocardial stunning. Does aspirin close the "second window" of endogenous cardioprotection? , 2003, Journal of the American College of Cardiology.
[388] P. Ferdinandy. Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia , 2003, British journal of pharmacology.
[389] Péter Ferdinandy,et al. Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2. , 2002, Biochemical and biophysical research communications.
[390] D. Liem,et al. Sites of action of adenosine in interorgan preconditioning of the heart. , 2002, American journal of physiology. Heart and circulatory physiology.
[391] D. Yellon,et al. A Comparison between Ischemic Preconditioning, Intermittent Cross-Clamp Fibrillation and Cold Crystalloid Cardioplegia for Myocardial Protection during Coronary Artery Bypass Graft Surgery , 2002, Cardiovascular surgery.
[392] M. Morice,et al. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. , 2002, Journal of the American College of Cardiology.
[393] D. Yellon,et al. The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. , 2002, Cardiovascular research.
[394] G. Heusch. Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? , 2001, Circulation.
[395] L. Opie,et al. Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium. , 2001, Journal of the American College of Cardiology.
[396] E. Pehkonen,et al. Effect of ischemic preconditioning on myocardial protection in coronary artery bypass graft patients : can the free radicals act as a trigger for ischemic preconditioning? , 2001, Chest.
[397] S. Yusuf,et al. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. , 2000, Progress in cardiovascular diseases.
[398] J. Cleveland,et al. Ischemic preconditioning in myocardial revascularization with intermittent aortic cross-clamping. , 2000 .
[399] F. Jatene,et al. Ischemic Preconditioning in Myocardial Revascularization with Intermittent Aortic Cross‐Clamping , 2000, Journal of cardiac surgery.
[400] Kenan Öuvoünç. Effects of glibenclamide, a k atp channel blocker, on warm‐up phenomenon in type 11 diabetic patients with chronic stable angina pectoris , 2000, Clinical cardiology.
[401] B. Sancak,et al. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? , 2000, Pharmacological research.
[402] K. Ovünç. Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina pectoris. , 2000, Clinical cardiology.
[403] Michael V. Cohen,et al. S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning. , 1999, American journal of physiology. Heart and circulatory physiology.
[404] Yuanyang Li,et al. Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[405] A. Bochenek,et al. Evaluation of perioperative myocardial tissue damage in ischemically preconditioned human heart during aorto coronary bypass surgery. , 1998, The Journal of cardiovascular surgery.
[406] G. Heusch,et al. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. , 1998, Journal of the American College of Cardiology.
[407] Z. Szilvássy,et al. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? , 1998, Trends in pharmacological sciences.
[408] R. Illes,et al. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. , 1998, The Annals of thoracic surgery.
[409] Z. Szilvássy,et al. Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. , 1997, Journal of molecular and cellular cardiology.
[410] W. Luo,et al. Preconditioning improves myocardial preservation in patients undergoing open heart operations. , 1997, The Annals of thoracic surgery.
[411] M. Karck,et al. Ischemic preconditioning prior to myocardial protection with cold blood cardioplegia in coronary surgery. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[412] M. Arad,et al. Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. , 1997, American journal of physiology. Heart and circulatory physiology.
[413] R. Kloner,et al. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. , 1997, Circulation.
[414] K. Peuhkurinen,et al. Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. , 1997, The Annals of thoracic surgery.
[415] D. Yellon,et al. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. , 1997, Heart.
[416] P. Menasché,et al. Ischemic preconditioning in cardiac surgery: a word of caution. , 1996, The Journal of thoracic and cardiovascular surgery.
[417] G. Heusch,et al. No attenuation of ischaemic preconditioning by the calcium antagonist nisoldipine. , 1996, Journal of molecular and cellular cardiology.
[418] Z. Szilvássy,et al. The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia. , 1995, Journal of molecular and cellular cardiology.
[419] D. Yellon,et al. Preconditioning the human heart during aorto-coronary bypass surgery. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[420] R. Kloner,et al. Regional Ischemic 'Preconditioning' Protects Remote Virgin Myocardium From Subsequent Sustained Coronary Occlusion , 1993, Circulation.
[421] R. Starling,et al. Cyclosporin inhibits mitochondrial calcium efflux in isolated adult rat ventricular cardiomyocytes. , 1992, The American journal of physiology.